Women SHINE Intervention for HIV/AIDS
What You Need to Know Before You Apply
What is the purpose of this trial?
A two-arm RCT will be conducted to test the efficacy of Women SHINE, a web-based trauma-informed peer navigation-social support intervention (Figure 2). A total of 360 women living with HIV/AIDS (WLHA) with a history of adulthood interpersonal violence who have been prescribed ART but are non-adherent (\< 90% ART adherent in the last 4 weeks) will be enrolled in the study. WLHA will be randomized (1:1) into one of the following conditions: 1) Women SHINE intervention arm (n=180) or 2) Control arm (n=180). The Women SHINE intervention arm will receive a four-month intervention including peer navigator (PN) one-on-one sessions, phone/text-based check-ins, 7 psychoeducation weekly support group sessions (120 mins.) co-facilitated by a licensed therapist and PN, and access to a static website with resources for HIV care, interpersonal violence, trauma, mental health, and substance use. The control arm will receive one group session (60 mins.) on self-care and well-being and access to the aforementioned website with resources. Women will complete a video-based survey and mailed hair sample self-collection at baseline, 4-, 8-, and 12-months post-randomization, to evaluate improvements in ART adherence (Aim 1), emotion regulation, and PTSD symptoms (Aim 2). Investigators will examine the mediating effect of individual (retention in HIV care, coping self-efficacy, social support, ancillary support services use) and socio-structural (stigma, medical mistrust) mechanisms of change on the efficacy of Women SHINE (Aim 3).
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, since participants must be currently prescribed ART (HIV medication), it seems you should continue taking it.
Is the Women SHINE Intervention safe for humans?
How does the Women SHINE treatment for HIV/AIDS differ from other treatments?
The Women SHINE treatment is unique because it combines web-based trauma-informed peer navigation and social support to help women with HIV/AIDS who have experienced sexual trauma. This approach focuses on building coping skills and improving engagement with HIV care, which is different from standard treatments that primarily focus on medication adherence.678910
What data supports the effectiveness of the Women SHINE Intervention for HIV/AIDS treatment?
Research shows that peer navigation, a key component of the Women SHINE Intervention, is effective in helping people with HIV engage in care and stick to their treatment. Studies in different settings have found that peer navigators can provide emotional support and help overcome barriers to care, which improves treatment outcomes.1231112
Who Is on the Research Team?
Jamila K Stockman, PhD, MPH
Principal Investigator
University of California, San Diego
Are You a Good Fit for This Trial?
This trial is for cisgender women over 18 living with HIV/AIDS who have experienced interpersonal violence as adults and are not fully adherent to their antiretroviral therapy (ART). Participants must speak English or Spanish, have internet access, and cannot be involved in another adherence intervention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Women SHINE intervention arm receives a four-month program including video-based peer navigation support, 7 weekly psychoeducation support group sessions, and access to a static website with resources.
Control
Control arm receives one 60-minute group session on self-care and well-being and access to a static website with resources.
Follow-up
Participants are monitored for improvements in ART adherence, PTSD symptoms, and emotion regulation at 4-, 8-, and 12-months post-randomization.
What Are the Treatments Tested in This Trial?
Interventions
- Control
- Women SHINE
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator